Dezima Pharma

Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia. Read more

Rob de Ree's photo - CEO of Dezima Pharma

CEO

Rob de Ree

CEO Approval Rating

69/100

Founded:

2012

Status:

PrivateSubsidiary of Amgen Inc

Est. Annual Revenue
Est. Employees
Sector

Update Industry

DEZIMA PHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Selcia is a top competitor of Dezima Pharma. Selcia is a Private company that was founded in 2001 in Essex, England. Selcia operates in the Pharmaceuticals industry. Compared to Dezima Pharma, Selcia has 48 more employees.

Vectura is seen as one of Dezima Pharma's biggest rivals. Vectura was founded in 1997, and is headquartered in Chippenham, England. Vectura operates in the Pharmaceuticals industry. Vectura generates $248.8M more revenue vs. Dezima Pharma.

Atomwise is seen as one of Dezima Pharma's top competitors. Atomwise was founded in San Francisco, California} in 2012. Atomwise competes in the Biotechnology industry. Compared to Dezima Pharma, Atomwise generates $5.1M less revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $10M a good estimate for Dezima Pharma's revenue?

Dezima Pharma Acquisitions

No recent acquisitions found related to Dezima Pharma

Dezima Pharma Funding History

Since Dezima Pharma was founded in 2012, it has participated in 1 round of funding. In total Dezima Pharma has raised $12.8M. Dezima Pharma's funding round was on Feb 2013 for a total of $12.8M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Feb 2013
$12.8M

Forbion Capital Partners

Since Dezima Pharma was founded in 2012, it has participated in 1 round of funding. In total Dezima Pharma has raised $12.8M. Dezima Pharma's funding round was on Feb 2013 for a total of $12.8M

Dezima Pharma Investments

No recent investments found related to Dezima Pharma

Dezima Pharma News

September 17, 2015PMLIVE

Amgen boosts pipeline with two deals topping $3bn

Acquires Dezima Pharma and signs collaboration with Xencor... See more »
September 17, 2015BIOCENTURY

Amgen buys Dezima

Amgen Inc. (NASDAQ:AMGN) will acquire Dezima Pharma B.V. (Naarden, the Netherlands) for $300 million ... See more »
September 16, 2015NEWSOK

Amgen buys 1 company, partners with 2nd to create new drugs

TRENTON, N.J. (AP) - Biotech drug giant Amgen is making deals to replenish its stock of medicines in ... See more »
September 16, 2015MARKETWATCH

Amgen to buy Dezima, signs pact with Xencor

Deals are aimed at expanding cardiovascular and immuno-oncology portfolios.... See more »
September 16, 2015BIOPORTFOLIO

Amgen Acquires Dezima Pharma for Cholesterol Drug Advantage

Amgen announced this morning it agreed to acquire Dezima Pharmaceuticals for $300 million in cash in ... See more »
September 16, 2015REUTERS

UPDATE 1-Amgen to buy Dezima Pharma for $300 mln in cash

Sept 16 (Reuters) - Amgen Inc said it will buy biotechnology company Dezima Pharma B.V., adding anoth... See more »

Dezima Pharma Press Releases

August 29, 2014BUSINESS WIRE

Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA-8995 in Dyslipidemia

NAARDEN, Netherlands--(BUSINESS WIRE)--Dezima Pharma ('Dezima'), the biotechnology company developing... See more »

Social Media

Dezima Pharma Headquarters

Gooimeer 2-35

Naarden, Noord-Holland1411

31-356-993-000

Driving Directions »

Trending Companies

Dezima Pharma Summary

ABOUT

Overview

Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia. Dezima Pharma was founded in 2012. Dezima Pharma's headquarters is located in Naarden, Noord-Holland, NL 1411. It has raised 12.8M in 1...

CEO

Dezima Pharma's CEO, Rob de Ree, currently has an approval rating of 69%. Dezima Pharma's primary competitors are Selcia, Vectura & Atomwise.

Frequently Asked Questions about Dezima Pharma

  1. When was Dezima Pharma founded?

    Dezima Pharma was founded in 2012
  2. Who is Dezima Pharma's CEO?

    Dezima Pharma's CEO is Rob de Ree
  3. How much revenue does Dezima Pharma generate?

    Dezima Pharma generates $10M in revenue
  4. How much funding does Dezima Pharma have?

    Dezima Pharma has historically raised $12.8M in funding
  1. Where is Dezima Pharma's headquarters?

    Dezima Pharma's headquarters is in Naarden Noord-Holland, NL
  2. How many employees does Dezima Pharma have?

    Dezima Pharma has 10 employees
  3. Who are Dezima Pharma's competitors?

    Dezima Pharma's top competitors are Selcia, Vectura, Atomwise